One-step colloidal synthesis of biocompatible water-soluble ZnS quantum dot/chitosan nanoconjugates

  • Fábio P Ramanery1,

    Affiliated with

    • Alexandra AP Mansur1 and

      Affiliated with

      • Herman S Mansur1Email author

        Affiliated with

        Nanoscale Research Letters20138:512

        DOI: 10.1186/1556-276X-8-512

        Received: 2 October 2013

        Accepted: 27 November 2013

        Published: 5 December 2013


        Quantum dots (QDs) are luminescent semiconductor nanocrystals with great prospective for use in biomedical and environmental applications. Nonetheless, eliminating the potential cytotoxicity of the QDs made with heavy metals is still a challenge facing the research community. Thus, the aim of this work was to develop a novel facile route for synthesising biocompatible QDs employing carbohydrate ligands in aqueous colloidal chemistry with optical properties tuned by pH. The synthesis of ZnS QDs capped by chitosan was performed using a single-step aqueous colloidal process at room temperature. The nanobioconjugates were extensively characterised by several techniques, and the results demonstrated that the average size of ZnS nanocrystals and their fluorescent properties were influenced by the pH during the synthesis. Hence, novel 'cadmium-free’ biofunctionalised systems based on ZnS QDs capped by chitosan were successfully developed exhibiting luminescent activity that may be used in a large number of possible applications, such as probes in biology, medicine and pharmacy.


        Nanoparticle Quantum dot Colloid Biopolymer Chitosan Bioconjugates Nanomaterials 81.07.Ta; 78.67.Hc; 78.67.Sc; 82.35.Pq


        Since the classic talk from Richard Feynman, titled 'There's plenty of room at the bottom’ , presented on 29 December 1959 at the annual meeting of the American Physical Society (at the California Institute of Technology, USA), introduced the concept of nanotechnology, this technology has evolved at an outstanding pace in practically all areas of sciences [1, 2]. To be considered as nanotechnology, nanosized and nanostructured systems should present one or more components with at least one dimension ranging from 1 to 100 nm. In recent years, innovation in nanotechnology and nanoscience for medicine (or nanomedicine) has been a major driving force in the creation of new nanocomposites and nanobioconjugates. Essentially, these materials may bring together the intrinsic functionalities of inorganic nanoparticles and the biointerfaces offered by biomolecules and polymers of natural origin, such as carbohydrates and derivatives, glycoconjugates, proteins, DNA, enzymes and oligopeptides [35].

        In view of the large number of available alternatives to produce hybrids and conjugates for bioapplications, carbohydrates have been often chosen, due to their biocompatibility, physicochemical and mechanical properties, and relative chemical solubility and stability in aqueous physiological environment [58]. Among these carbohydrates, chitosan (poly-β(1 → 4)-2-amino-2-deoxy-d-glucose) is one of the most abundant polysaccharides (semi-processed) from natural sources, second only to cellulose [58]. Chitosan is a polycationic polymer that has been broadly used in pharmaceuticals, drug carrier and delivery systems, wound dressing biomaterial, antimicrobial films, biomaterials, food packaging and many applications [510]. Chitosan is mainly produced from the alkaline deacetylation of chitin (usually extracted from the shells of marine crustaceans, such as crabs and shrimps), forming a copolymer composed of N-acetyl-d-glucosamine and d-glucosamine units available in different grades, depending upon the content of the acetylated moieties [58]. The degree of deacetylation (DD) and the molar mass (MM) of chitosan influence its properties, such as solubility in water, mechanical behaviour, chemical stability and biodegradability. Similarly, there are several alternatives of one-dimensional and zero-dimensional nanostructured inorganic materials, such as nanotubes, nanowires, nanorods and quantum dots, that are suitable for conjugation with carbohydrates to produce hybrid nanomaterials for bioapplications [1113]. Quantum dots (QDs) are ultra-small semiconductor nanocrystals that consist of numbers of atoms in the range of a few thousands. Owing to their reduced dimension, QDs exhibit discrete electronic energy levels that give rise to unique electronic, optical and magnetic properties [1316]. They have rapidly emerged as a new class of fluorescent nanomaterials for a boundless number of applications, primarily as probes in biology, medicine and pharmacy. Having many advantages over organic dyes, such as broad excitation and resistance to photobleaching, QDs are one of the most exciting tools for use in nanotechnology, nanomedicine and nanobiotechnology areas [13]. However, to be used in biological conditions, QDs must exhibit compatibility to the water-based physiological medium in which the large number of natural macromolecules exist. Therefore, surface chemical engineering of QDs is required to render them water soluble and biocompatible. Surprisingly, reports on the surface bio-functionalisation of QDs with chitosan and its derivatives are scarcely found in the literature [5, 1720], and only recently has the direct synthesis of CdS QDs using chitosan and chemically modified chitosans in aqueous colloidal dispersion been published by our group [1719]. Despite the noticeable advances in the synthesis of nanohybrids based on the conjugation of QDs and biomolecules, to date, most published studies and commercial QDs are synthesised through the traditional organometallic method and contain toxic elements, such as cadmium, lead and mercury, using organic solvents and ligands (trioctyl phosphine/trioctyl phosphine oxide, TOP/TOPO) at high temperatures. Presently, the most commonly used QDs contain divalent cadmium, widely known as a toxin, due to the accumulation of Cd2+ in tissues and organs [13, 21, 22]. Although Cd2+ is incorporated into a nanocrystalline core (as components of low-solubility sulphides or selenides) covered by another semiconductor 'shell’ like ZnS and surrounded by biologically compatible ligands, such as polymers, amino acids, proteins and carbohydrates [2327], it is still unclear if these toxic ions will impact the use of QDs as clinical luminescent probes for biomedical applications. Consequently, great concern has been raised over the toxicity of QDs made by heavy-metal cores in living cells, animals and humans, and in the environment as the long-term impact is not entirely understood [5, 22]. In that sense, 'cadmium-free’ nanomaterials are very promising alternatives, such as zinc compounds [5, 28], due to their natural environmental abundance. Zinc divalent cations (Zn2+) are commonly found in nature, in forms varying from mineral inorganic sources to several living organisms as crucial metabolic species.

        Thus, this research focused on demonstrating the synthesis of ZnS quantum dots directly capped by chitosan using a facile, reproducible and economical single-step aqueous processing method at room temperature. Moreover, the nanohybrid systems were extensively characterised, and the strong influence of pH on the formation of the semiconductor nanocrystals and their fluorescent response was verified. The novel colloidal biofunctionalised water-soluble nanoconjugates made of ZnS-QDs/chitosan are potentially non-toxic and, combined with their luminescent properties, offer great potential for use in various biomedical and environmentally friendly applications.



        All reagents and precursors, zinc chloride (Sigma-Aldrich, St. Louis, MO, USA, ≥98%, ZnCl2), sodium sulphide (Synth, São Paulo, Brazil, >98%, Na2S · 9H2O), sodium hydroxide (Merck, Whitehouse Station, NJ, USA, ≥99%, NaOH), acetic acid (Synth, São Paulo, Brazil, ≥99.7%, CH3COOH) and hydrochloric acid (Sigma-Aldrich, St. Louis, MO, USA, 36.5% to 38.0%, HCl), were used as received. Chitosan powder (Aldrich, St. Louis, MO, USA, MM = 310,000 to >375,000 g/mol, DD ≥ 75.0% and viscosity 800 to 2,000 cP, at 1% in 1% acetic acid) was used as the reference ligand. Deionised water (DI-water; Millipore Simplicity™, Billerica, MA, USA) with a resistivity of 18 MΩ cm was used in the preparation of all solutions. All preparations and synthesis were performed at room temperature (23°C ± 2°C) unless specified.

        Synthesis of ZnS quantum dots

        ZnS nanoparticles were synthesised via an aqueous route in a reaction flask at room temperature as follows: 2 mL of chitosan solution (1% w/v in 2% v/v aqueous solution of acetic acid) and 45 mL of DI-water were added to the flask reacting vessel. The pH value of this solution was adjusted to 4.0 ± 0.2, 5.0 ± 0.2 or 6.0 ± 0.2 with NaOH (1.0 mol.L-1). Under moderate magnetic stirring, 4.0 mL of Zn2+ precursor solution (ZnCl2, 8 × 10-3 mol.L-1) and 2.5 mL of S2- precursor solution (Na2S · 9H2O, 1.0 × 10-2 mol.L-1) were added to the flask (S/Zn molar ratio was kept at 1:2) and stirred for 60 min. The obtained ZnS QD suspensions, referred to as QD_ZnS_4, QD_ZnS_5 and QD_ZnS_6, as a function of the pH of quantum dot synthesis, were clear and colourless, and sampling aliquots of 3.0 mL were collected at different time intervals (after preparation, 20 min, 1 h and 24 h) for UV-visible (UV–vis) spectroscopy measurements that were performed for colloidal stability evaluation.

        Characterisation of the ZnS quantum dots and chitosan capping agent

        UV–vis spectroscopy measurements were conducted using PerkinElmer equipment (Lambda EZ-210, Waltham, MA, USA) in transmission mode with samples in a quartz cuvette over a wavelength range of 600 to 190 nm. All experiments were conducted in triplicate (n = 3) unless specifically noted, and data was presented as mean ± standard deviation.

        Photoluminescence (PL) characterisation of the ZnS-chitosan (CHI) conjugates was conducted based on spectra acquired at room temperature using the Nanodrop 3300 fluoro-spectrometer (Thermo Scientific, UV LED with λexcitation = 365 ± 10 nm). The relative activity was calculated by subtracting the backgrounds of the samples without QDs. All tests were performed using a minimum of four repetitions (n ≥ 4). In addition, QD colloidal media were placed inside a 'darkroom chamber’ , where they were illuminated by a UV radiation emission bulb (λexcitation = 365 nm, 6 W, Boitton Instruments, Porto Alegre, Brazil). Digital colour images were collected of the fluorescence of the QDs in the visible range of the spectrum.

        X-ray diffraction (XRD) patterns were recorded using a PANalytical X'Pert diffractometer (Cu-Kα radiation with λ = 1.5406 Å, Almelo, The Netherlands). Measurements were performed in the 2θ range of 15° to 75° with steps of 0.06°.

        Nanostructural characterisations of the QD bioconjugates, based on the images and selected area electron diffraction (SAED) patterns, were obtained using a Tecnai G2-20-FEI transmission electron microscope (TEM; Hillsboro, OR, USA) at an accelerating voltage of 200 kV. Energy-dispersive X-ray (EDX) spectra were collected using the TEM for element chemical analysis. In all the TEM analyses, the samples were prepared by dropping the colloidal dispersion onto a porous carbon grid. The QD size and size distribution data were obtained based on the TEM images by measuring at least 100 randomly selected nanoparticles using an image processing program (ImageJ, version 1.44, public domain, National Institutes of Health).

        ZnS-CHI quantum dots were analysed by diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) method (Thermo Fischer, Nicolet 6700, Waltham, MA, USA) over the range of 400 to 4,000 cm-1 using 64 scans and a 2-cm-1 resolution. These samples were prepared by placing a droplet of the chitosan solution or ZnS-chitosan dispersions onto KBr powder and drying at the temperature of 60°C ± 2°C for 24 h.

        For potentiometric titration studies, dried chitosan (0.20 g) was dissolved in 20 mL of 0.10 mol.L-1 HCl with gentle stirring overnight and diluted with 20 mL of DI-water. Under continuous stirring, 100 μL of 0.10 mol.L-1 sodium hydroxide solution was added, then allowed to equilibrate, and the pH recorded using a pH meter with a glass electrode (Quimis, Diadema, Brazil). This sequence was repeated until neutralisation of the HCl, and deprotonation of amine groups occurred. DD was calculated using Equation 1 [29]:
        DD = M NaOH × V 2 - V 1 × MM CHI / m CHI × 100

        where MNaOH is the molar concentration of NaOH solution (mol.L-1) used to neutralise a solution of mCHI (g) of chitosan in 0.1 mol.L-1 HCl. V2 (L) is the volume of NaOH added until neutralisation of the ammonium ions from chitosan, and V1 (L) is the volume of NaOH added to cause the neutralisation of HCl in excess. MMCHI is the molecular mass of glucosamine units (161 g.mol-1).

        The extent of protonation (EPpH) of chitosan can be calculated from Equation 2:
        EP pH = 100 % NH 2 × 100 / DD

        where% NH2 is the amount of non-protonated amine groups estimated from Equation 1 considering that V2 is equal to the added volume of base to neutralise the ammonium ions from chitosan at the pH of interest (4.0, 5.0 and 6.0).

        Zeta potential analyses were performed using a Brookhaven ZetaPALS instrument with a laser light wavelength of 660 nm (35-mW red diode laser, Holtsville, NY, USA). Standard square acrylic cells with a volume of 4.5 mL were used. The zeta potential measurements were performed at (25.0°C ± 2°C) under the Smoluchowski approximation [30], and 100 runs (five measurements of 20 cycles) were chosen for a good reproducibility.


        Characterisation of ZnS quantum dots capped by chitosan

        UV–vis spectroscopy

        The UV–vis absorption spectra of the ZnS nanoparticles produced using chitosan as the stabilising ligand (ZnS-chitosan nanoconjugates) are shown in Figure 1A. The curves exhibit a broad absorption band between 250 and 360 nm associated with the first excitonic transition indicating that ZnS nanocrystals were synthesised within the 'quantum confinement regime’ [31] at different pH to form colloidal suspensions capped by carbohydrate-based ligands (after 24 h). The band gap of quantum dots may be assessed by theoretical, semi-empirical and empirical models. In this study, the optical band gap energy (EQD) was assessed from absorption coefficient data as a function of wavelength using the 'Tauc relation’ [32]. This procedure allows to estimate the dimensions of nanoparticles in diluted colloidal suspensions in situ once the average size of the ZnS nanocrystals can be estimated using the empirical model published in the literature [33, 34], which relates the nanoparticle size (r) to the EQD from a UV–vis spectrum (Equation 3):
        r E QD = 0.32 - 2.9 × E QD - 3.49 1 / 2 / 2 × 3.50 - E QD
        Figure 1

        UV–vis spectroscopy analysis. (A) Spectra of ZnS-chitosan conjugates synthesised at different pH. (B) Optical band gap using the Tauc relation of ZnS-chitosan conjugates synthesised at different pH. (a) pH = 4.0, (b) pH = 5.0, (c) pH = 6.0. Inset: analysis of the effect of pH during the synthesis on the average ZnS quantum dot size (2r) and respective band gap energy (EQD).

        The EQD values extracted from the curves using the Tauc relation (Figure 1B) were equal to 3.74 ± 0.02, 3.79 ± 0.02 and 3.92 ± 0.02 eV for pH = 4.0, 5.0 and 6.0, respectively. These band gap values are higher than the reference bulk value of 3.54 to 3.68 eV for ZnS with a cubic structure, the difference (EQD - Eg) being referred to as 'blue shift’ [35, 36]. Additionally, based on EQD results, the average sizes (diameter, 2r) were calculated (Equation 4) to be 4.7 ± 0.1, 4.4 ± 0.1 and 3.8 ± 0.1 nm for pH = 4.0, 5.0 and 6.0, respectively. Statistical analysis showed that the pH of the synthesis has influenced optical properties and nanoparticle dimensions (Student's t test, 95% confidence coefficient; 0.05 significance level), as shown in Figure 1B (inset). The summary of the results extracted from the UV-visible spectra and optical absorbance analysis is presented in Table 1.
        Table 1

        Parameters of ZnS QDs capped by chitosan as a function of pH during the synthesis





        Blue shift (eV)

        Size, 2r(nm)

        Bulka = 3.61


        4.0 ± 0.1

        318 ± 2

        3.74 ± 0.02

        0.13 ± 0.02

        4.7 ± 0.1


        5.0 ± 0.1

        312 ± 2

        3.79 ± 0.02

        0.18 ± 0.02

        4.4 ± 0.1


        6.0 ± 0.1

        280 ± 2

        3.92 ± 0.02

        0.31 ± 0.02

        3.8 ± 0.1

        aReference bulk value for ZnS (cubic crystalline structure).

        Photoluminescence spectroscopy analysis

        Based on the absorbance curves and the band gap energies evaluated under excitation, ZnS-chitosan bioconjugates were expected to emit light in the UV range (Eg ≥ 3.6 eV). However, the occurrence, population and depths of the traps determine the pathway that the electron–hole (e-/h+) pair generated by the absorption of light will follow, i.e. recombine and produce the emission of light and/or undergo non-radiative decay. ZnS quantum dots typically exhibit emission peaks in the 400 to 550 nm wavelength range that is primarily associated with point defects, such as vacancies (V) and interstitial ions (I) and also surface defects [20, 37, 38]. The band edge (excitonic) emission from ZnS, being related to more organised and highly crystalline materials, has been sparsely detected [37, 38]. Figure 2 shows the photoluminescence spectra collected at room temperature (RT) of the nanoparticle-biopolymer systems under evaluation. From a general perspective, the band edge recombination was not detected, and other bands in the violet-blue range were observed (Figure 2, inset). According to the energy level diagrams reported by Wageh et al. [38] and Becker and Bard [39], the high-energy emission bands (wavelengths below 450 nm) observed in the spectra are associated with the Vs (vacancies of sulphur, S2-) and IZn (Zn2+ at interstitial sites at the lattice) defects because they may be favoured by the synthesis of the nanoparticles under the condition of an excess of metal atoms, compatible with the procedure used in this work using a stoichiometric molar ratio of Zn2+/S2- = 2:1. In addition, because vacancy states lie deeper in the band gap than do the states arising from interstitial atoms in colloidal ZnS [3840], the emission band of QD_ZnS_4 and QD_ZnS_5 identified at about 418 nm (2.97 eV) is due to transitions involving interstitial states, while the emission around 440 nm (2.82 eV) is assigned to vacancy states. The band at approximately 470 nm (2.63 eV), observed for all systems (independent to the pH of the synthesis), may be assigned to surface defects [38].
        Figure 2

        PL spectra of ZnS-chitosan conjugates at pH = 4.0, pH=5.0, and pH = 6.0. Inset: blue luminescence under UV excitation.

        XRD analysis

        The XRD patterns of ZnS QDs prepared at different pH have presented similar peak profiles, with a relative increase of the peak broadening related to the rise of the pH of QD preparation (Figure 3). The three peaks observed in the patterns at 2θ ~ 28.7°, 2θ ~ 48.0° and 2θ ~ 56.3° could be assigned to the planes (111), (220) and (311) of ZnS of the cubic lattice structure (zinc blend also referred to as sphalerite, JCPDS 05–0566). This crystalline form has been reported by several authors for nanoparticles of ZnS, despite hexagonal wurtzite being the stable polymorph of ZnS bulk at ambient temperatures [4143]. The peak broadening observed in XRD patterns is associated with the formation of small crystals [41, 43]. Besides, for the smaller particles, the peak broadening is larger and peaks overlap in a large extent. Based on these features, the obtained XRD profiles are in accordance with the results of nanoparticle dimensions estimated by UV–vis spectra with the smaller crystallite size related to the higher pH of the synthesis.
        Figure 3

        XRD patterns of ZnS quantum dots synthesised at different pH. (a) pH = 4.0, (b) pH = 5.0, (c) pH = 6.0.

        TEM morphological analysis

        In this study, the morphological and structural features of the quantum dots were characterised using TEM coupled to an EDX microprobe and using SAED analysis. Figure 4 shows representative samples of ZnS QDs produced with the chitosan at pH 4.0 ± 0.2 (A), pH 5.0 ± 0.2 (B) and pH 6.0 ± 0.2 (C) with spherical shape. EDX spectra show the chemical analysis of the nanocrystals with Zn and S as the major elements (Figure 4A, inset), excluding the copper, oxygen and carbon peaks related to the TEM grid and the polymer stabiliser. The electron diffraction pattern of the QDs with a lattice parameter comparable to the ZnS cubic crystal (JCPDS 05–0566) is shown in Figure 4A (inset). The histogram of the QD_ZnS_4 size distribution (Figure 4A) indicates a monodisperse distribution with an average size of 5.1 ± 0.3 nm. Analogously, QD_ZnS_5 and QD_ZnS_6 samples exhibited reasonably monodisperse nanoparticles, with an average size centred at approximately 4.7 ± 0.4 nm (Figure 4B) and 4.4 ± 0.4 nm (Figure 4C), respectively. Thus, the TEM results demonstrated that ZnS quantum dots were properly stabilised by chitosan, in reasonable agreement with the values obtained from the UV–vis optical absorbance in the previous section for QD_ZnS_4 (2r = 4.7 ± 0.1 nm), QD_ZnS_5 (2r = 4.4 ± 0.1 nm) and QD_ZnS_6 (2r = 3.8 ± 0.1 nm).
        Figure 4

        TEM and EDX analysis. (A) TEM image and particle size distribution histogram of QD_ZnS_4 bioconjugates. Inset: EDX spectrum and nanocrystal plane spacing. TEM images and particle size distribution histograms of (B) QD_Zn_5 and (C) QD_ZnS_6.

        FTIR spectroscopy analysis

        Fourier transform infrared (FTIR) spectroscopy is commonly used to better understand the local nano-microenvironment of the ligands at the QD surface. In some cases, it has proven to be the most important technique for the characterization of the interactions between the ligand and the quantum dot [35, 44]. The FTIR spectrum of chitosan copolymer (Additional file 1: Figure S1) presents absorption peaks at 1,645 and 1,560 cm-1 which are assigned to the carbonyl stretching of the secondary amides (amide I band) and the N-H bending vibrations of the deacetylated primary amine (-NH2) and amide II band, respectively. NH vibrations (stretching) also occur within the 3,400 to 3,200 cm-1 region overlapping the OH stretch from the carbohydrate ring. In addition, the absorptions at 1,030 to 1,040 cm-1 and 1,080 to 1,100 cm-1 indicate the C-O stretching vibration in chitosan, which are associated with the C6-OH primary alcohol and the C3-OH secondary alcohol, respectively [6, 19, 45]. These amine, amide and hydroxyl groups are the most reactive sites of chitosan and are involved in the chemical modifications of this carbohydrate and in the interactions of chitosan with cations and anions [46, 47].

        After conjugating the quantum dots with the capping biopolymer (curves (b) in Figure 5 and Additional file 2: Figure S2), there were several bands of chitosan in the FTIR spectra (curves (a) in Figure 5 and Additional file 2: Figure S2) that exhibited changes in their energies (i.e. wavenumber). These changes can be mainly attributed to the interactions occurring between the functional groups of the chitosan ligand (amine/acetamide and hydroxyls) and the ZnS QDs. For example, in the spectra of the bioconjugated QDs (Figure 5), the amide I band (1,650 cm-1) shifted to a lower wavenumber by 7 cm-1 for the ZnS nanoconjugates synthesised at pH 4.0 and 6.0. The amine band (bending NH, at 1,560 cm-1) was 'red-shifted’ (i.e. shifted to a lower energy) by approximately 6 cm-1 for QD_ZnS_6 and 9 cm-1 for QD_ZnS_4. A significant change was also observed in the region from 1,000 to 1,200 cm-1, which was essentially associated with -OH groups (alcohol groups). The band associated with the primary alcohol (C6-OH) vibration was red-shifted by 13 cm-1 for QD_ZnS_6 and 18 cm-1 for QD_ZnS_4. The peak assigned to C3-OH (secondary alcohol) stretching shifted its position to a lower energy by 38 cm-1 for QD_ZnS_6 and 15 cm-1 for QD_ZnS_4. Figure 5C summarises the red shift of bands related to functional groups of chitosan after bioconjugation as a function of pH. Additionally, at all the pH concentrations under evaluation, the wide peak of chitosan at 3,385 cm-1 (Additional file 3: Figure S3), corresponding to the stretching vibration of -NH2 and -OH groups, became significantly narrower after stabilisation of the quantum dots. This peak narrowing indicates the reduction of 'free’ amine groups after quantum dot stabilisation [35].
        Figure 5

        FTIR spectra results. (a) Chitosan and (b) ZnS-chitosan bioconjugates at (A) pH 6.0 ± 0.2 and (B) pH = 4.0 ± 0.2. Vibrational regions: 1,750 to 1,475 cm-1 (left) and 1250–950 cm-1 (right). (C) Relative 'red-shift’ of bands associated with the functional groups of chitosan after the formation of ZnS bioconjugates as a function of pH. (D) Schematic representation of some interactions at ZnS-chitosan nanointerfaces (not to scale).

        Based on the FTIR analyses, the primary and secondary alcohols and the amine and acetamide (carboxyl) groups in chitosan were determined to have interacted with the ZnS quantum dots. The differences between the FTIR spectra of chitosan before and after conjugation with ZnS nanocrystals can be assigned to the formation of coordination complexes between chitosan and zinc cations (Zn2+) on the surfaces of the QDs, with the participation of the amino and/or hydroxyl functional groups, besides carboxyl groups from acetamide [44, 48, 49]. Metal ions have been suggested to be chelated with the NH2, OH and NH-CO-CH3 groups in the chitosan chain as mono- and/or multidentate ligands (Figure 5D), depending on the type and concentration of the metal species, the functional derivative groups and the pH level [47, 49, 50].

        Characterisation of the chitosan capping agent

        From the curve of the potentiometric titration of chitosan (Additional file 4: Figure S4), the DD was calculated to be equal to 75% ± 2% (in accordance with the specification from the manufacturer, ≥75.0%), and EPpH was estimated to be 100%, 92% and 60% at pH levels of 4.0, 5.0 and 6.0, respectively, which are consistent with previous studies reported in the literature [51].

        Aiming at a more in-depth investigation, the characterisation of the chitosan by zeta potential measurements was performed, thus providing information on the possible chemical interactions occurring at the chitosan-quantum dot interfaces. Figure 6 shows the zeta potential of the chitosan solutions at different pH levels with EPpH data. These results indicated a decrease of the surface charge with an increasing pH level ranging from +65 mV at pH 3.5 to approximately 0 mV close to pH 6.0. These results follow the same trend as that of the extent of protonation as a function of pH: a higher potential zeta value was measured for a higher content of -NH3+ groups, as depicted in Figure 6.
        Figure 6

        Zeta potential curve of chitosan solutions at different pH. Calculated values of the 'extent of protonation’ with the respective schematic representation of chitosan polymer conformation/charges (range from 3.5 to 6.0).


        The UV–vis absorption spectra were used to monitor the formation of ZnS QDs capped with chitosan and also to calculate some optical properties of these nanocrystals. The results of EQD of the ZnS QDS synthesised at different pH were larger than that of the original bulk material (Eg), demonstrating that semiconductor nanoparticles with dimensions below the 'Bohr radius’ were produced. It should be highlighted that these results are notably relevant as far as the direct synthesis of semiconductor nanocrystals in aqueous media is concerned because ZnS QDs were nucleated and stabilised at ultra-small sizes using a water-soluble biocompatible polysaccharide. In fact, to the best of our knowledge, this is the first report where cadmium-free bioconjugates based on ZnS QDs were directly produced and stabilised by chitosan at room temperature using strictly water colloidal chemistry. To obtain these results, the carbohydrate ligand must cap and stabilise the ZnS nuclei at the very early stages of the reaction that formed the water colloidal suspensions. Moreover, the ZnS nuclei should have surpassed the thermodynamic factor for growing the QD nuclei and agglomeration that is driven by the minimisation of the system surface energy. The kinetic aspects of the reaction of Zn2+ with S2- for producing ZnS nanocrystals must be considered as very favourable, due to the free energy (ΔG < 0), and a 'burst of nuclei’ is observed due to the high reaction rate (i.e. very low 'solubility product constant’ , Ksp = ~10-24) [52].

        From the perspective of using chitosan as the stabiliser ligand, additional considerations may be drawn regarding the formation of ZnS nanocrystals. Chitosan is considered to be a pH-sensitive polymer and a weak base in aqueous solutions, with a pKa value of approximately 6.5 [53]. This pKa value leads to the protonation of the amine groups in acid solutions according to Equation 4:
        CHI NH 2 aq + H + aq CHI NH 3 + aq

        Considering Equation 4 and the results presented in Figure 6, under acidic conditions (pH < pKa), the amine group of chitosan is protonated to various degrees, depending on the pH of the solution: the lower the pH value (referenced to pKa), the higher the extension of the protonation (NH2 → NH3+). However, note that despite the presence of the protonated groups, the surface charge of chitosan at pH 6.0 tends towards zero, which could be due to the conformation of the chitosan chains. At lower pH levels, almost all of the amine groups are protonated, thus repealing each other and thereby favouring the chitosan-water interaction, which overcomes the associative forces between chains. At higher pH levels, the number of -NH3+ species and the net of the interchain repulsive electrostatic forces are reduced. Hydrogen bonds and hydrophobic interactions between chains will be more favourable, thus promoting the formation of a more compact structure [54, 55].

        As a consequence, a significant influence of pH on the formation/growth/stabilisation and optical properties of the ZnS QDs in chitosan colloidal solution was observed (as depicted in Figure 1B, inset). Based on the UV–vis spectroscopy results, when the pH was raised from 4 to 6, the average nanocrystal size decreased by approximately 20% (from 4.7 to 3.8 nm). Additionally, a similar trend was observed from XRD and TEM analyses: an increase in the pH of the medium caused a reduction on the average QD size. The decrease in size could be attributed to the sum of several contributions towards the formation of the nanoconjugates made by the ZnS 'core’ and chitosan 'shell’. At a relatively lower pH (pH = 4), most of the amine groups of chitosan are protonated (pH < < pKa of chitosan); thereby, positively charged transition metal has to compete with hydrogen ion for complexation with amine electron pair (metal-ligand interactions), as represented in Equations 5 and 6 [50]:
        Chitosan NH 2 aq + H + aq Chitosan NH 3 + aq
        Chitosan NH 3 + aq + Zn 2 + aq Chitosan NH 2 / Zn 2 + aq + H + aq

        However, as the pH increases (pH = 6), more amine groups become available in the chitosan chain for dative bonding (electron donor) with zinc divalent cations, thus reducing the electrostatic repulsion (Zn2+ ↔ NH3+) and favouring the stabilisation of the ZnS nanocrystals at smaller dimensions due to the increase of the number of nucleation sites.

        It is also interesting to note that the shift of the secondary alcohol vibration in FTIR spectra of conjugates was inversely proportional to the extent of protonation. Both the amine/protonated amine and the C3-OH group are at the same side of the chitosan chain. The presence of a higher number of -NH3+ charged groups may affect the interaction of -OH groups with metal cations (Zn2+) during the nucleation, growth and stabilisation of QDs. Additionally, sulphide anions (S2-) may have electrostatically interacted with -NH3+ groups of chitosan during the synthesis of ZnS QDs at lower pH, which could also affect the sizes of the nanocrystals formed.

        In addition, photoluminescence properties were also affected by pH. The PL relative efficiency of the CHI-ZnS bioconjugates was higher under more acidic synthesis conditions (pH = 4.0). PL quenching may be attributed to several features. In this case, at relatively higher pH levels (pH = 5.0 and pH = 6.0), the smaller sizes of the nanoparticles were observed, and most of the amine groups were deprotonated (pH closer to pKa). As the nanoparticle size decreases, surface disorder and dangling bonds may dominate the luminescence properties, thus creating non-radiative pathways that dissipate quantum dot emission, which resulted in the decreased PL intensity [56, 57]. Considering spherical quantum dots, as the nanoparticle size reduces (radius, R), the relative surface (S) to volume (V) ratio (S/V = 4πR2 / (4/3)πR3) = 3/R) is significantly increased leading to more surface defects. Additionally, amine groups can act as hole scavengers, which quench the photoluminescence [58].


        In the present work, ZnS QDs directly biofunctionalised by chitosan were synthesised using a single-step colloidal process in aqueous medium at room temperature. The results demonstrated that varying the pH from 4.0 to 6.0 of the chitosan solutions significantly affected the average size of ZnS nanocrystals produced ranging from 3.8 to 4.7 nm. The results indicated the stabilisation of ZnS conjugates by the interaction of the functional groups of chitosan, amines, acetamides and hydroxyls, with Zn2+ at the surface of QDs. Additionally, the pH of the solution induced important effects on the optical fluorescent behaviour of the ZnS-chitosan bioconjugates which was assigned to the 'trap states’ emissions involving the defect states of the QDs. Hence, new cadmium-free biocompatible colloids based on ZnS QDs capped by chitosan were successfully developed exhibiting luminescent activity that may be tuned by adjusting the pH with great potential for use in biomedical and eco-friendly applications.



        The authors acknowledge the financial support from CAPES, FAPEMIG and CNPq. The authors express their gratitude to the staff from the Microscopy Centre/UFMG for the TEM analysis.

        Authors’ Affiliations

        Center of Nanoscience, Nanotechnology and Innovation - CeNano2I, Department of Metallurgical and Materials Engineering, Escola de Engenharia, Federal University of Minas Gerais


        1. Feynman RP: There's plenty of room at the bottom. Eng Sci 1960, 23: 22–36.
        2. Toumey CP: Reading Feynman into nanotechnology. Techné: Res Philos Technol 2008, 12: 133–168. 10.5840/techne20081231
        3. Emerich DF: Nanomedicine – prospective therapeutic and diagnostic applications. Expert Opin Biol Ther 2005, 5: 1–5. 10.1517/14712598.5.1.1View Article
        4. Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, Cullough J: The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine 2013, 9: 1–14.View Article
        5. Tan WB, Huang N, Zhang Y: Ultrafine biocompatible chitosan nanoparticles encapsulating multi-coloured quantum dots for bioapplications. J Colloid Interface Sci 2007, 310: 464–470. 10.1016/j.jcis.2007.01.083View Article
        6. Costa-Júnior ES, Barbosa-Stancioli EF, Mansur AAP, Vasconcelos WL, Mansur HS: Preparation and characterization of chitosan/poly(vinyl alcohol) chemically crosslinked blends for biomedical applications. Carbohydr Polym 2009, 76: 472–481. 10.1016/j.carbpol.2008.11.015View Article
        7. Dash M, Chiellini F, Ottenbrite RM, Chiellini E: Chitosan—a versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci 2011, 36: 981–1014. 10.1016/j.progpolymsci.2011.02.001View Article
        8. Rinaudo M: Chitin and chitosan: properties and applications. Prog Polym Sci 2006, 31: 603–632. 10.1016/j.progpolymsci.2006.06.001View Article
        9. Xia W, Liu P, Zhang J, Chen J: Biological activities of chitosan and chitooligosaccharides. Food Hydrocoll 2011, 25: 170–179. 10.1016/j.foodhyd.2010.03.003View Article
        10. Zhang J, Xia W, Liu P, Cheng Q, Tahi T, Gu W, Li B: Chitosan modification and pharmaceutical/biomedical applications. Mar Drugs 2010, 8: 1962–1987. 10.3390/md8071962View Article
        11. Božanić DK, Djoković D, Bibić N, Nair PS, Georges MK, Radhakrishnan T: Biopolymer-protected CdSe nanoparticles. Carbohydr Res 2009, 344: 2383–2387. 10.1016/j.carres.2009.08.018View Article
        12. Chaudhuri RJ, Paria S: Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization, and applications. Chem Rev 2012, 112: 2373–2433. 10.1021/cr100449nView Article
        13. Mansur HS: Quantum dots and nanocomposites. WIRES Nanomeb Nanobi 2010, 2: 113–129. 10.1002/wnan.78View Article
        14. Wang H, Wang T, Wang X, Liu R, Wang B, Wang H, Xu Y, Zhang J, Duan J: Double-shelled ZnO/CdSe/CdTe nanocable arrays for photovoltaic applications: microstructure evolution and interfacial energy alignment. J Mater Chem 2012, 22: 12532–12537. 10.1039/c2jm32253fView Article
        15. Wang X, Zhu H, Xu Y, Wang H, Tao Y, Hark S, Xiao X, Li Q: Aligned ZnO/CdTe core-shell nanocable arrays on indium tin oxide: synthesis and photoelectrochemical properties. ACS Nano 2010, 22: 3302–3308.View Article
        16. Wang B, Ding H, Hu Y, Zhou H, Wang S, Wang T, Liu R, Zhang J, Wang X, Wang H: Power conversion efficiency enhancement of various size CdS quantum dots and dye co-sensitized solar cells. Int J Hydrogen Energ 2013, 38: 16733–16739. 10.1016/j.ijhydene.2013.03.062View Article
        17. Mansur HS, Mansur AAP, Curti E, de Almeida MV: Bioconjugation of quantum-dots with chitosan and N, N, N-trimethyl chitosan. Carbohydr Polym 2012, 90: 189–196. 10.1016/j.carbpol.2012.05.022View Article
        18. Mansur HS, Mansur AAP, Curti E, de Almeida MV: Functionalized-chitosan/quantum dots nano-hybrids for nanomedicine applications: towards biolabeling and biosorbing phosphate metabolites. J Mater Chem B 2013, 1: 1696–1711. 10.1039/c3tb00498hView Article
        19. Santos JCC, Mansur AAP, Mansur HS: One-step biofunctionalization of quantum dots with chitosan and N-palmitoyl chitosan for potential biomedical applications. Molecules 2013, 18: 6550–6572. 10.3390/molecules18066550View Article
        20. Chang S-Q, Kang B, Dai Y-D, Zhang H-X, Chen D: One-step fabrication of biocompatible chitosan coated ZnS and ZnS:Mn2+ quantum dots via gamma-radiation route. Nanoscale Res Lett 2011, 6: 591. 10.1186/1556-276X-6-591View Article
        21. Green M: The nature of quantum dot capping ligands. J Mater Chem 2010, 20: 5797–5809. 10.1039/c0jm00007hView Article
        22. Yong K-T, Law W-C, Hu R, Ye L, Liu L, Swihart MT, Prasad PN: Nanotoxicity assessment of quantum dots: from cellular to primate studies. Chem Soc Rev 2013, 42: 1236–1250. 10.1039/c2cs35392jView Article
        23. Mansur HS, Mansur AAP: CdSe quantum dots stabilized by carboxylic-functionalized PVA: synthesis and UV–vis spectroscopy characterization. Mater Chem Phys 2011, 125: 709–717. 10.1016/j.matchemphys.2010.09.068View Article
        24. Mansur HS, Mansur AAP, González JC: Synthesis and characterization of CdS quantum dots with carboxylic-functionalized poly (vinyl alcohol) for bioconjugation. Polymer 2011, 52: 1045–1054. 10.1016/j.polymer.2011.01.004View Article
        25. Mansur HS, Mansur AAP, González JC: Biomolecule-quantum dot systems for bioconjugation applications. Colloids Surf B: Biointerfaces 2011, 84: 360–368. 10.1016/j.colsurfb.2011.01.027View Article
        26. Mansur HS, Mansur AAP, González JC: Enzyme-polymers conjugated to quantum-dots for sensing applications. Sensors 2011, 11: 9951–9972. 10.3390/s111009951View Article
        27. Mansur HS, Mansur AAP: Fluorescent nanohybrids: quantum-dots coupled to polymer-recombinant protein conjugates for the recognition of biological hazards. J Mater Chem 2012, 22: 9006–9018. 10.1039/c2jm31168bView Article
        28. Mehta SK, Kumar S, Gradzielski M: Growth, stability, optical and photoluminescent properties of aqueous colloidal ZnS nanoparticles in relation to surfactant molecular structure. J Colloid Interface Sci 2011, 360: 497–507. 10.1016/j.jcis.2011.04.079View Article
        29. Torres MA, Vieira RS, Beppu MM, Santana CC: Produção e caracterização de microesferas de quitosana modificadas quimicamente. Polímeros 2005, 15: 306–312. in Portuguese in PortugueseView Article
        30. Delgado AV, González-Caballero F, Hunter RJ, Koopal LK, Lyklema J: Measurement and interpretation of electrokinetic phenomena. Pure Appl Chem 2005, 77: 1753–1805. 10.1351/pac200577101753
        31. Brus LE: Electron–electron–hole in small semiconductors crystallites: the size dependence of the lowest excited electronic state. J Chem Phys 1984, 80: 4403–4409. 10.1063/1.447218View Article
        32. Tauc J, Menth A: States in the gap. J Non-Cryst Solids 1972, 8–10: 569–585.View Article
        33. Jaiswal A, Sanpui P, Chattopadhyay A, Ghosh SS: Investigating fluorescence quenching of ZnS quantum dots by silver nanoparticles. Plasmonics 2011, 6: 125–132. 10.1007/s11468-010-9177-0View Article
        34. Mall M, Kumar L: Optical studies of Cd2+ and Mn2+ Co-doped ZnS nanocrystals. J Lumin 2010, 130: 660–665. 10.1016/j.jlumin.2009.11.012View Article
        35. Cooper JK, Franco AM, Gul S, Corrado C, Zhang JZ: Characterization of primary amine capped CdSe, ZnSe, and ZnS quantum dots by FT-IR: determination of surface bonding interaction and identification of selective desorption. Langmuir 2011, 27: 8486–8493. 10.1021/la201273xView Article
        36. Fang J, Holloway PH, Yu JE, Jones KS, Pathangey B, Brettschneider E, Anderson TJ: MOCVD growth of non-epitaxial and epitaxial ZnS thin films. Appl Surf Sci 1993, 70/71: 701–706.View Article
        37. Chen R, Li D, Liu B, Peng Z, Gurzadyan GG, Xiong O, Sun H: Optical and excitonic properties of crystalline ZnS nanowires: toward efficient ultraviolet emission at room temperature. Nano Lett 2010, 10: 4956–4961. 10.1021/nl102987zView Article
        38. Wageh S, Ling ZS, Xu-Rong X: Growth and optical properties of colloidal ZnS nanoparticles. J Cryst Growth 2003, 255: 332–337. 10.1016/S0022-0248(03)01258-2View Article
        39. Becker WG, Bard AJ: Photoluminescence and photoinduced oxygen adsorption of colloidal zinc sulfide dispersions. J Phys Chem 1983, 87: 4888–4893. 10.1021/j150642a026View Article
        40. Denzler D, Olschewski M, Sattler K: Luminescence studies of localized gap states in colloidal ZnS nanocrystals. J Appl Phys 1998, 84: 2841–2845. 10.1063/1.368425View Article
        41. Tarasov K, Houssein D, Destarac M, Marcotte N, Gérardin C, Tichit D: Stable aqueous colloids of ZnS quantum dots prepared using double hydrophilic block copolymers. New J Chem 2013, 37: 508–514. 10.1039/c2nj40738hView Article
        42. Zheng Y, Gao S, Ying JY: Synthesis and cell-imaging applications of glutathione-capped CdTe quantum dots. Adv Mater 2007, 19: 376–380. 10.1002/adma.200600342View Article
        43. Barman B, Sarma KC: Luminescence properties of ZnS quantum dots embedded in polymer matrix. Chalcogenide Lett 2011, 8: 171–176.
        44. Li Z, Du Y, Zhang Z, Pang D: Preparation and characterization of CdS quantum dots chitosan biocomposite. React Funct Polym 2003, 55: 35–43. 10.1016/S1381-5148(02)00197-9View Article
        45. Mansur HS, Costa ES Jr, Mansur AAP, Barbosa-Stancioli EB: Cytocompatibility evaluation in cell-culture systems of chemically crosslinked chitosan/PVA hydrogels. Mater Sci Eng C 2009, 29: 1574–1583. 10.1016/j.msec.2008.12.012View Article
        46. Riva R, Ragelle H, Des Rieux A, Duhem N, Jérôme C, Préat V: Chitosan and chitosan derivatives in drug delivery and tissue engineering. Adv Polym Sci 2011, 244: 19–44. 10.1007/12_2011_137View Article
        47. Varma AJ, Deshpande SV, Kennedy JF: Metal complexation by chitosan and its derivatives: a review. Carbohydr Polym 2004, 55: 77–93. 10.1016/j.carbpol.2003.08.005View Article
        48. Rangel-Mendeza R, Monroy-Zepedab R, Leyva-Ramosb E, Diaz-Floresa PE, Shirai K: Chitosan selectivity for removing cadmium (II), copper (II), and lead (II) from aqueous phase: pH and organic matter effect. J Hazard Mater 2009, 162: 503–511. 10.1016/j.jhazmat.2008.05.073View Article
        49. Rivas JCM, Salvagni E, Parsons S: Investigating the effect of hydrogen bonding environments in amide cleavage reactions at zinc(II) complexes with intramolecular amide oxygen co-ordination. Dalton Trans 2004, 21: 4185–4192.View Article
        50. Wang XH, Du YM, Liu H: Preparation, characterization and antimicrobial activity of chitosan–Zn complex. Carbohydr Polym 2004, 56: 21–26. 10.1016/j.carbpol.2003.11.007View Article
        51. Hasan S, Ghosh TK, Viswanath DS, Boddu VM: Dispersion of chitosan on perlite for enhancement of copper (II) adsorption capacity. J Hazard Mater 2008, 152: 826–837. 10.1016/j.jhazmat.2007.07.078View Article
        52. Wang M, Zhang Q, Hao W, Sun Z–X: Surface stoichiometry of zinc sulphide and its effect on the adsorption behaviors of xanthate. Chem Cent J 2011, 5: 73. 10.1186/1752-153X-5-73View Article
        53. Sonia TA, Sharma CP: Chitosan and its derivatives for drug delivery perspective. Adv Polym Sci 2011, 243: 23–54. 10.1007/12_2011_117View Article
        54. Chenite A, Buschmann M, Wang D, Chaput C, Kandani N: Rheological characterization of thermogelling chitosan/glycerol-phosphate solutions. Carbohydr Polym 2001, 46: 39–47. 10.1016/S0144-8617(00)00281-2View Article
        55. Claesson PM, Ninham BW: pH dependent interactions between adsorbed chitosan layers. Langmuir 1992, 8: 1406–1412. 10.1021/la00041a027View Article
        56. Kalyuzhny G, Murray RW: Ligand effects on the optical properties of CdSe nanocrystals. J Phys Chem B 2005, 109: 7012–7021. 10.1021/jp045352xView Article
        57. Landes CF, Braun M, El-Sayed MA: On the nanoparticle to molecular size transition: fluorescence quenching studies. J Phys Chem B 2011, 105: 10554–10558.View Article
        58. Baker DR, Kamat PV: Tuning the emission of CdSe quantum dots by controlled trap enhancement. Langmuir 2010, 26: 11272–11276. 10.1021/la100580gView Article


        © Ramanery et al.; licensee Springer. 2013

        This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.